World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
27841
World Ranking
14555
National Ranking
7367

Overview

Eric M. Horwitz is affiliated with the Fox Chase Cancer Center in the United States. Their research focuses primarily on medicine, with significant contributions in pulmonary and respiratory medicine, radiation, surgery, radiology, nuclear medicine and imaging, as well as economics and econometrics.

Their main research topics emphasize prostate cancer treatment and research, prostate cancer diagnosis and treatment, and advanced radiotherapy techniques. Additional areas of study include health systems, economic evaluations, quality of life, cancer, lipids, and metabolism, radiomics and machine learning in medical imaging, and bladder and urothelial cancer treatments.

Frequent coauthors in their work include:

  • J.K. Wong
  • Brian J. Davis
  • M.A. Hallman
  • Juanita Crook
  • Phuoc T. Tran

Eric M. Horwitz has frequently published in the following venues:

  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • Brachytherapy
  • The Journal of Urology
  • European Urology

Recent notable papers include:

  • "NCCN Guidelines Insights: Prostate Cancer, Version 1.2021," 2021, Journal of the National Comprehensive Cancer Network
  • "A War on Two Fronts: Cancer Care in the Time of COVID-19," 2020, Annals of Internal Medicine
  • "Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management," 2022, The Journal of Urology
  • "Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up," 2022, The Journal of Urology
  • "Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate," 2020, JAMA Oncology

Best Publications

  • Prostate cancer. Clinical practice guidelines in oncology.

    James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby

  • Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    James L. Mohler;Emmanuel S. Antonarakis;Andrew J. Armstrong;Anthony V. D'Amico

  • Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

    Gerald E. Hanks;Thomas F. Pajak;Arthur Porter;David Grignon

  • Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer

    Eric M. Horwitz;Kyounghwa Bae;Gerald E. Hanks;Arthur Porter

  • Prostate Cancer, Version 1.2016

    James L. Mohler;Andrew J. Armstrong;Robert R. Bahnson;Anthony Victor D'Amico

  • Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

    J. M Crook;C. J O'Callaghan;G Duncan;D. P Dearnaley

  • Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.

    Michael J. Zelefsky;Deborah A. Kuban;Larry B. Levy;Louis Potters

  • Causes of death among cancer patients

    Nicholas G. Zaorsky;T. M. Churilla;B. L. Egleston;S. G. Fisher

  • American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy

    Brian J. Davis;Eric M. Horwitz;W. Robert Lee;Juanita M. Crook

  • Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

    Alan Pollack;Gail Walker;Eric M. Horwitz;Robert Price

  • A War on Two Fronts: Cancer Care in the Time of COVID-19.

    Alexander Kutikov;David S. Weinberg;Martin J. Edelman;Eric M. Horwitz

  • Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911

    Corey J. Langer;Jonathan Harris;Eric M. Horwitz;Nicos Nicolaou

  • Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology

    James L. Mohler;Philip W. Kantoff;Andrew J. Armstrong;Robert R. Bahnson

  • Prostate cancer, version 1.2021: Featured updates to the nccn guidelines

    Edward Schaeffer;Sandy Srinivas;Emmanuel S. Antonarakis;Andrew J. Armstrong

  • Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.

    Amar U. Kishan;Ryan R. Cook;Jay P. Ciezki;Ashley E. Ross

  • Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era ☆

    Deborah A Kuban;Howard D Thames;Larry B Levy;Eric M Horwitz

  • Long-Term Survival After Radical Prostatectomy Versus External Beam Radiotherapy for Patients with High-Risk Prostate Cancer

    Stephen A. Boorjian;R. Jeffrey Karnes;Rosalia Viterbo;Laureano J. Rangel

  • Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors.

    Di Yan;John Wong;Frank Vicini;Jeff Michalski

  • Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines

    James L. Mohler;Andrew J. Armstrong;Robert R. Bahnson;Barry Boston

  • Intermittent Androgen Suppression for Rising PSA Level After Radiotherapy

    Juanita M. Crook;Christopher J. O’Callaghan;Graeme Duncan;David P. Dearnaley

Frequent Co-Authors

Alan Pollack
Alan Pollack University of Miami
Robert G. Uzzo
Robert G. Uzzo Fox Chase Cancer Center
Alexandra L. Hanlon
Alexandra L. Hanlon Virginia Tech
Gerald E. Hanks
Gerald E. Hanks Fox Chase Cancer Center
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
Patrick A. Kupelian
Patrick A. Kupelian University of California, Los Angeles
Jeff M. Michalski
Jeff M. Michalski Washington University in St. Louis
Alvaro Martinez
Alvaro Martinez Beaumont Health
Deborah A. Kuban
Deborah A. Kuban The University of Texas MD Anderson Cancer Center
Michael J. Zelefsky
Michael J. Zelefsky Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional MD program in the USA isn’t the only pathway to enter the healthcare sector. Many students are now considering flexible and affordable options through online programs in related fields. For those interested in healthcare leadership and management, a healthcare administration degree online provides skills in policy, finance, and operations.

Students who want to advance further may look into an affordable mha online to open doors to executive and administrative roles. For nurses seeking clinical leadership, finding the cheapest dnp program online can be a cost-effective way to achieve the highest practice-focused nursing degree.

Likewise, aspiring pharmacists might explore a 3-year online pharmd program, allowing them to earn a doctorate in pharmacy with flexibility and affordability. These alternative online programs offer practical routes into high-demand healthcare careers while accommodating diverse learning needs and schedules.

Best Scientists Citing Eric M. Horwitz

Trending Scientists

Recently Published Articles